| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2000;69:1484-1489
© 2000 The Society of Thoracic Surgeons
a Department of Pediatric Cardiovascular Surgery, The Heart Institute of Japan, Tokyo Women’s Medical College, Tokyo, Japan
Address reprint requests to Dr Nemoto, Laboratories of Cardiac Molecular and Cellular Physiology, Department of Medicine-Cardiology, Veterans Affairs Medical Center, Baylor College of Medicine, Room 243, Building 110, 2002 Holcombe Blvd, Houston, TX 77030
e-mail: snemoto{at}bcm.tmc.edu
Background. Hemolysis caused by cardiopulmonary bypass causes renal dysfunction and other organ failure presumably by superoxide production catalyzed by iron derived from free hemoglobin (f-Hb). It might also impair cardiac function by the same mechanism, especially in the ischemia-reperfusion period and in neonates where serum antioxidant activity is lower than adults.
Methods. We evaluated effects of f-Hb on cardiac function with or without ischemia and reperfusion using a newborn (7 days old) rabbit crystalloid-perfused Langendorff model. After baseline measurements, the hearts were divided into the following four groups (8 hearts per group): (1) those perfused with regular Krebs-Henseleit bicarbonate buffer, (2) those perfused 30 minutes with KH buffer containing 1 mg/mL of f-Hb obtained from osmotic hemolysis, (3) those subjected to 180 minutes of cold global ischemia with infusion of crystalloid cardioplegia and reperfused with Krebs-Henseleit buffer, and (4) those subjected to the same ischemia and reperfused with Krebs-Henseleit buffer containing 1 mg/mL of f-Hb. The left ventricular function (using conductance catheter and isovolumic balloon) and coronary flow were measured.
Results. Free hemoglobin significantly impaired not only left ventricular function but also coronary flow even without ischemia (p < 0.05). When ischemia and reperfusion were involved, the group reperfused with f-Hb showed the worst left ventricular function and coronary flow among the groups.
Conclusions. This study shows that f-Hb directly impaired cardiac function and coronary flow in neonatal hearts especially in ischemia and reperfusion.
This article has been cited by other articles:
|
|
 |
|
  S.-Y. P. K. Shiao and C.-N. Ou Validation of Oxygen Saturation Monitoring in Neonates Am. J. Crit. Care., March 1, 2007; 16(2): 168 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Philippidis, J.C. Mason, B.J. Evans, I. Nadra, K.M. Taylor, D.O. Haskard, and R.C. Landis Hemoglobin Scavenger Receptor CD163 Mediates Interleukin-10 Release and Heme Oxygenase-1 Synthesis: Antiinflammatory Monocyte-Macrophage Responses In Vitro, in Resolving Skin Blisters In Vivo, and After Cardiopulmonary Bypass Surgery Circ. Res., January 9, 2004; 94(1): 119 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Caputo, M. Yeatman, P. Narayan, G. Marchetto, R. Ascione, B. C. Reeves, and G. D. Angelini Effect of off-pump coronary surgery with right ventricular assist device on organ function and inflammatory response: a randomized controlled trial Ann. Thorac. Surg., December 1, 2002; 74(6): 2088 - 2095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hayashi, M. Ohtani, T. Soma, and Y. Sasako Aortic valve replacement for a patient with warm-reactive autoimmune hemolytic anemia Eur. J. Cardiothorac. Surg., December 1, 2002; 22(6): 1026 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hayashi, K. Kagisaki, T. Yamaguchi, T. Sakaguchi, Y. Naka, Y. Sawa, S. Ohtake, and H. Matsuda Clinical application of vacuum-assisted cardiopulmonary bypass with a pressure relief valve Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 621 - 626. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
